XML 91 R43.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Earnings Per Common Share (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2019
Earnings Per Share [Abstract] |
Schedule of computation of basic and diluted earnings per share (in thousands, except per share amounts) | The following table illustrates the computation of basic and diluted earnings per share (in thousands, except per share amounts):
| Year Ended December 31,
| 2019 |  | 2018 |  | 2017
Numerator |  |  |  |  |
Net income (loss) | $ | 60,061 |  |  | $ | 1,073,474 |  |  | $ | 422,634 |
Noncontrolling interests' share in earnings | (14,531 | ) |  | (12,381 | ) |  | (8,465 | )
Net income (loss) attributable to Healthpeak Properties, Inc. | 45,530 |  |  | 1,061,093 |  |  | 414,169 |
Less: Participating securities' share in earnings | (1,543 | ) |  | (2,669 | ) |  | (1,156 | )
Net income (loss) applicable to common shares | $ | 43,987 |  |  | $ | 1,058,424 |  |  | $ | 413,013 |
Numerator - Dilutive |  |  |  |  |
Net income (loss) applicable to common shares | $ | 43,987 |  |  | $ | 1,058,424 |  |  | $ | 413,013 |
Add: distributions on dilutive convertible units and other | — |  |  | 6,919 |  |  | — |
Dilutive net income (loss) available to common shares | $ | 43,987 |  |  | $ | 1,065,343 |  |  | $ | 413,013 |
Denominator |  |  |  |  |
Basic weighted average shares outstanding | 486,255 |  |  | 470,551 |  |  | 468,759 |
Dilutive potential common shares - equity awards | 309 |  |  | 168 |  |  | 176 |
Dilutive potential common shares - forward equity agreements(1) | 2,771 |  |  | — |  |  | — |
Dilutive potential common shares - DownREIT conversions | — |  |  | 4,668 |  |  | — |
Diluted weighted average common shares | 489,335 |  |  | 475,387 |  |  | 468,935 |
Earnings per common share |  |  |  |  |  |  |  |
Basic | $ | 0.09 |  |  | $ | 2.25 |  |  | $ | 0.88 |
Diluted | $ | 0.09 |  |  | $ | 2.24 |  |  | $ | 0.88 |
(1) Represents the current dilutive impact of 30 million shares of common stock under forward sales agreements that have not been settled as of December 31, 2019. Based on the forward price of each agreement as of December 31, 2019, issuance of all 30 million shares would result in approximately $1.00 billion of net proceeds.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration